We have a dedicated program manager coordinating the various subgroups to ensure timely execution, foster crosstalk, and promote scientific and public engagement.
Stefan Irion, MD
Memorial Sloan Kettering
Information for Patients
Our research has laid the foundation for new therapy under investigation for Parkinson’s disease. However, for the therapy to be realized, every step must be taken with caution, and conclusions must be scrutinized from every angle.
This study is not yet recruiting participants, but interested individuals are encouraged to contact the investigatory team for more information.